Buckley Wealth Management’s Biogen BIIB Stock Holding History

Buckley Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,170	Closed	-$327K	–	131
2021 Q1	$327K	Sell	1,170 -367	-24%	-$99K	0.12%	102
2020 Q4	$376K	Sell	1,537 -101	-6%	-$26.1K	0.15%	92
2020 Q3	$465K	Buy	1,638 +100	+7%	+$27.9K	0.21%	76
2020 Q2	$411K	Hold	1,538	–	–	0.19%	89
2020 Q1	$487K	Hold	1,538	–	–	0.26%	77
2019 Q4	$456K	Hold	1,538	–	–	0.21%	85
2019 Q3	$358K	Buy	1,538 +29	+2%	+$6.75K	0.18%	100
2019 Q2	$353K	Buy	1,509 +543	+56%	+$125K	0.17%	113
2019 Q1	$228K	Hold	966	–	–	0.11%	135
2018 Q4	$291K	Sell	966 -13	-1%	-$4.15K	0.15%	116
2018 Q3	$346K	Buy	979 +2	+0.2%	+$689	0.15%	123
2018 Q2	$284K	Sell	977 -25	-2%	-$7.03K	0.13%	136
2018 Q1	$274K	Sell	1,002 -52	-5%	-$16.1K	0.14%	140
2017 Q4	$336K	Buy	+1,054	New	+$338K	0.17%	123

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Buckley Wealth Management's BIIB Position: Q2 2021 in Review

Buckley Wealth Management sold out of Biogen (BIIB) in Q2 2021, closing a stake of 1,170 shares — an estimated $327K sold.

Buckley Wealth Management first reported a position in BIIB in Q4 2017 and held it in 14 quarters. The position peaked at $487K in Q1 2020. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

Buckley Wealth Management reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
Buckley Wealth Management sold 1,170 Biogen shares in Q2 2021, an estimated $327K.
Buckley Wealth Management first reported a position in Biogen in Q4 2017 and held it in 14 quarters.
Buckley Wealth Management's Biogen position peaked at $487K in Q1 2020.
1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Buckley Wealth Management's 13F filing for Q2 2021, filed 27 Jul 2021.